127 related articles for article (PubMed ID: 31756160)
21. A generic method for intact and subunit level characterization of mAb charge variants by native mass spectrometry.
Leblanc Y; Faid V; Lauber MA; Wang Q; Bihoreau N; Chevreux G
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Dec; 1133():121814. PubMed ID: 31731217
[TBL] [Abstract][Full Text] [Related]
22. Characterization of variable regions of monoclonal antibodies by top-down mass spectrometry.
Zhang Z; Shah B
Anal Chem; 2007 Aug; 79(15):5723-9. PubMed ID: 17591752
[TBL] [Abstract][Full Text] [Related]
23. High-Throughput Therapeutic Antibody Interference-Free High-Resolution Mass Spectrometry Assay for Monitoring M-Proteins in Multiple Myeloma.
Santockyte R; Puig O; Zheng N; Ouyang Z; Titsch C; Zhang YJ; Pillutla R; Zeng J
Anal Chem; 2021 Jan; 93(2):834-842. PubMed ID: 33300779
[TBL] [Abstract][Full Text] [Related]
24. Prospective applications of ultrahigh resolution proteomics in clinical mass spectrometry.
Ruhaak LR; van der Burgt YE; Cobbaert CM
Expert Rev Proteomics; 2016 Dec; 13(12):1063-1071. PubMed ID: 27798968
[TBL] [Abstract][Full Text] [Related]
25. Top-Down Mass Spectrometry: Proteomics to Proteoforms.
Patrie SM
Adv Exp Med Biol; 2016; 919():171-200. PubMed ID: 27975217
[TBL] [Abstract][Full Text] [Related]
26. Assessment of meat authenticity using bioinformatics, targeted peptide biomarkers and high-resolution mass spectrometry.
Ruiz Orduna A; Husby E; Yang CT; Ghosh D; Beaudry F
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2015; 32(10):1709-17. PubMed ID: 26241836
[TBL] [Abstract][Full Text] [Related]
27. Automated generic analysis tools for protein quantitation using stable isotope labeling.
Hsu WL; Sung TY
Methods Mol Biol; 2010; 604():257-72. PubMed ID: 20013376
[TBL] [Abstract][Full Text] [Related]
28. Multiplexed Middle-Down Mass Spectrometry as a Method for Revealing Light and Heavy Chain Connectivity in a Monoclonal Antibody.
Srzentić K; Nagornov KO; Fornelli L; Lobas AA; Ayoub D; Kozhinov AN; Gasilova N; Menin L; Beck A; Gorshkov MV; Aizikov K; Tsybin YO
Anal Chem; 2018 Nov; 90(21):12527-12535. PubMed ID: 30252447
[TBL] [Abstract][Full Text] [Related]
29. Isotope Depletion Mass Spectrometry (ID-MS) for Accurate Mass Determination and Improved Top-Down Sequence Coverage of Intact Proteins.
Gallagher KJ; Palasser M; Hughes S; Mackay CL; Kilgour DPA; Clarke DJ
J Am Soc Mass Spectrom; 2020 Mar; 31(3):700-710. PubMed ID: 32003978
[TBL] [Abstract][Full Text] [Related]
30. A Spike-Control Approach that Evaluates High Resolution Mass Spectrometry-Based Sequence Variant Analytical Method Performance for Therapeutic Proteins.
Zhang J; Shih M; Yan H; O'Connor T; Ji C; Faustino PJ
Pharm Res; 2023 Jun; 40(6):1425-1433. PubMed ID: 37127779
[TBL] [Abstract][Full Text] [Related]
31. A workflow for absolute quantitation of large therapeutic proteins in biological samples at intact level using LC-HRMS.
Jian W; Kang L; Burton L; Weng N
Bioanalysis; 2016 Aug; 8(16):1679-91. PubMed ID: 27487386
[TBL] [Abstract][Full Text] [Related]
32. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.
Reusch D; Haberger M; Falck D; Peter B; Maier B; Gassner J; Hook M; Wagner K; Bonnington L; Bulau P; Wuhrer M
MAbs; 2015; 7(4):732-42. PubMed ID: 25996192
[TBL] [Abstract][Full Text] [Related]
33. Top-down analysis of immunoglobulin G isotypes 1 and 2 with electron transfer dissociation on a high-field Orbitrap mass spectrometer.
Fornelli L; Ayoub D; Aizikov K; Liu X; Damoc E; Pevzner PA; Makarov A; Beck A; Tsybin YO
J Proteomics; 2017 Apr; 159():67-76. PubMed ID: 28242452
[TBL] [Abstract][Full Text] [Related]
34. An in-line enzymatic microreactor for the middle-up analysis of monoclonal antibodies by capillary electrophoresis.
Dadouch M; Ladner Y; Bich C; Larroque M; Larroque C; Morel J; Bonnet PA; Perrin C
Analyst; 2020 Mar; 145(5):1759-1767. PubMed ID: 31913378
[TBL] [Abstract][Full Text] [Related]
35. LC-MS bioanalysis of intact proteins and peptides.
Kang L; Weng N; Jian W
Biomed Chromatogr; 2020 Jan; 34(1):e4633. PubMed ID: 31257628
[TBL] [Abstract][Full Text] [Related]
36. Serum Insulin-like Growth Factor I Quantitation by Mass Spectrometry: Insights for Protein Quantitation with this Technology.
Kam RK; Ho CS; Chan MH
EJIFCC; 2016 Dec; 27(4):318-330. PubMed ID: 28149264
[TBL] [Abstract][Full Text] [Related]
37. Validation of lipidomic analysis of human plasma and serum by supercritical fluid chromatography-mass spectrometry and hydrophilic interaction liquid chromatography-mass spectrometry.
Wolrab D; Chocholoušková M; Jirásko R; Peterka O; Holčapek M
Anal Bioanal Chem; 2020 Apr; 412(10):2375-2388. PubMed ID: 32078000
[TBL] [Abstract][Full Text] [Related]
38. The way forward, enhanced characterization of therapeutic antibody glycosylation: comparison of three level mass spectrometry-based strategies.
Wagner-Rousset E; Bednarczyk A; Bussat MC; Colas O; Corvaïa N; Schaeffer C; Van Dorsselaer A; Beck A
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Sep; 872(1-2):23-37. PubMed ID: 18672411
[TBL] [Abstract][Full Text] [Related]
39. Six-step workflow for the quantification of therapeutic monoclonal antibodies in biological matrices with liquid chromatography mass spectrometry - A tutorial.
El Amrani M; Donners AAM; Hack CE; Huitema ADR; van Maarseveen EM
Anal Chim Acta; 2019 Nov; 1080():22-34. PubMed ID: 31409472
[TBL] [Abstract][Full Text] [Related]
40. Investigating the utility of minimized sample preparation and high-resolution mass spectrometry for quantification of monoclonal antibody drugs.
Nguyen TTTN; Mistarz UH; Costa N; Herbet A; Boquet D; Becher F; Rand KD
J Pharm Biomed Anal; 2018 Sep; 159():384-392. PubMed ID: 30071466
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]